Ossiform ApS
Ossiform is founded on proprietary technology to 3D print patient specific, natural, and resorbable bone implants. This enables fast ingrowth of bone tissue, remodeling into real living bone, and results in fewer complications. Today, Ossiform uses its award-winning technology to develop revolutionary bone implants, including implants that are designed to deliver additives such as pharmaceuticals and growth factors with wide ranging benefits for patients.
The technology is further used to provide 3D printed R&D products for enhancing bone and cancer research. The bone-like scaffolds provide a clinically relevant cell culture system of natural materials and customized structures – applicable across in vitro and in vivo tests – that enable the creation of predictive research models of human physiology and pathology.
Company profiles, product categories, and areas of interest are written and added by the suppliers and are not based on knowledge or assessment from FoodTech.
Responsibility for content on this site
Information, images, product descriptions, videos, certifications, sustainability claims, and other content on company profiles are uploaded and maintained by the individual exhibitors.
Exhibitors are solely responsible for ensuring that their content is accurate, properly documented, and legally compliant, including compliance with applicable regulations concerning marketing, sustainability claims, and intellectual property rights.
MCH A/S solely provides the platform and does not, as a general rule, verify the content.